184 / 464
184
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
POSTERS
> The independent benefit deriving from high doses and WPRT in
salvage post-prostatectomy radiotherapy
C. Cozzarini, B. Noris Chiorda, C. Fiorino, M. Pasetti (Italy),
A. Briganti, C.L. Deantoni, A.M. Deli, A. Fodor, N. Fossati, G. Gandaglia,
C. Sini, F. Montorsi, N. Di Muzio
PO-0730
> Comparison of two fractionation schemes in prostate cancer patients
treated with robotic SBRT
F. Akyol, P. Hurmuz, G. Ozyigit (Turkey)
PO-0731
> Toxicity and outcome in moderately hypofractionated radiotherapy for
590 prostate cancer patients
A. Maucieri (Italy), B.A. Jereczek-Fossa, D. Ciardo, C. Fodor,
P. Maisonneuve, A. Surgo, S. Volpe, G. Marvaso, A. Vavassori, A. Viola,
G. Musi, O. De Cobelli, R. Orecchia
PO-0732
> Radium 223: difference in clinical outcomes between young and old
Y.P. Song (UK), T. Ellis, R. Walshaw, J. Logue, O. Parikh, A. Choudhury
PO-0733
> The effect of TAB duration and pelvic RT in prostate cancers with
gleason score 8-10: TROG study
G. Ozyigit (Turkey), C. Onal, S. Igdem, Z. Arican Alicikus, A. Iribas,
M. Akin, D. Yalman, I. Cetin, M.G. Aksu, B. Atalar, F. Dincbas,
B. Aydin, F. Sert, C. Yildirim, I.B. Gorken, F.Y. Agaoglu, A.F. Korcum,
S. Ozkok, E. Darendeliler, F. Akyol
PO-0734
> HDR-brachytherapy or SBRT for extreme hypofractionation in prostate
cancer - long-term results
S. Aluwini (The Netherlands), W. Busser, M. Kroon, B. Heijmen
PO-0735
> Long term outcomes of IG-IMRT dose-escalation to pelvis and prostate
for advanced prostate cancer
H. Lieng (Canada), T. Rosewall, H. Jiang, A. Berlin, R. Bristow,
C. Catton, P. Chung, J. Helou, P. Warde, A. Bayley
PO-0736
> Elective pelvic radiotherapy in clinically node-negative prostate cancer:
a long-term analysis
F. Catucci, C. Masciocchi, A.R. Alitto (Italy), M. Vernaleone,
G.C. Mattiucci, V. Frascino, V. Valentini, G. Mantini
PO-0737
> PET with 18F-Choline for evaluation of prostate cancer patients with
biochemical relapse/persistence